XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Contract revenue   $ 318 $ 6 $ 700
Type of Revenue [Extensible List] cbio:ContractMember cbio:ContractMember cbio:ContractMember cbio:ContractMember
Operating expenses:        
Research and development $ 5,575 $ 3,805 $ 13,235 $ 9,286
General and administrative 2,770 2,391 8,909 7,407
Total operating expenses 8,345 6,196 22,144 16,693
Loss from operations (8,345) (5,878) (22,138) (15,993)
Interest and other income, net 651 85 2,920 185
Net loss (7,694) (5,793) (19,218) (15,808)
Deemed dividend for convertible preferred stock beneficial conversion feature       (3,951)
Net loss attributable to common stockholders $ (7,694) $ (5,793) $ (19,218) $ (19,759)
Net loss per share attributable to common stockholders, basic and diluted $ (0.64) $ (1.34) $ (1.75) $ (6.49)
Shares used to compute net loss per share attributable to common stockholders, basic and diluted 11,942,729 4,310,561 10,967,750 3,043,919